A ventricular assist device (VAD) helps pump blood from your heart to the rest of your body. It’s used when your heart is not able to pump enough blood on its own. The device consists of a pump, tubes ...

Ventricular assist devices are mechanical pumps that take over the function of the damaged ventricle in order to re-establish normal hemodynamics and end-organ blood flow. In addition, VADs unload the ...

The systemwide training helped standardize care for ventricular assist devices patients. Emergency care teams across the UAB ...

Heart failure is one of the most pressing health challenges of our time, affecting over 64 million people worldwide and driving significant mortality, morbidity, and healthcare costs. As donor heart ...

Despite major advances in the treatment of heart failure over the past 2 decades improving the natural history of this condition, heart failure continues to be a major source of morbidity and ...

At any one time in this country 50 to 100,000 people are suffering from heart failure, but only about 2,000 people a year receive heart transplants. For some people, an LVAD device can help patients ...

VADs are usually classified according to the mode of blood flow, namely pulsatile or continuous. Continuous types can be further subdivided based on the biomechanics of the pump: centrifugal or axial.

After receiving only the fourth US implant of a new-generation, Utah-made ventricular assist device, an Idaho man with heart failure is looking forward to resuming an active life following an ...

Austin, TX, USA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Left Ventricular Assist Devices Market Size, Trends and Insights By Product (Left ...

Mechanical circulatory support systems for the treatment of end-stage heart failure are now available for a wide variety of clinical situations and support times. Extracorporeal membrane oxygenation ...

LONDON--(BUSINESS WIRE)--The ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. Request free ...

A team led by Children's Hospital Los Angeles has become the first in the world to demonstrate the possibility of using genetically engineered pig hearts as a potential "bridge" to heart transplant ...